Earnings calendar/CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter CLOVER HEALTH INVESTMENTS, CORP. /DE has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$0.05
Est. $0.04 · +29.5%
Revenue
$743.2M
Est. $728.3M · +2.0%
Net income
$28.0M
As filed
EPS YoY
+350.0%
vs quarter ended 2025-06-30
Revenue YoY
+55.6%
vs quarter ended 2025-06-30
Next report
Nov 4, 2026
Third-party calendar date, not confirmed by a company filing · est. EPS $-0.00
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-0.05
2025-09-30 through 2026-06-30
TTM revenue
$2.48B
2025-09-30 through 2026-06-30
Filed quarters
30
On record here
EPS at or above estimate (4Q)
50%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-07 | $0.05 | $743.2M | +350.0% | +55.6% | $0.04 | +29.5% |
| 2026-03-31Q1 FY2026 | 2026-05-08 | $0.05 | $749.2M | — | +62.0% | $0.07 | -28.6% |
| 2025-12-31Q4 FY2025 | 2026-02-27 | $-0.10 | $487.7M | -233.3% | +44.7% | $-0.10 | +2.1% |
| 2025-09-30Q3 FY2025 | 2025-11-07 | $-0.05 | $496.6M | -150.0% | +50.1% | $0.02 | -350.0% |
| 2025-06-30Q2 FY2025 | 2025-08-08 | $-0.02 | $477.6M | -300.0% | +34.1% | $-0.01 | -117.4% |
| 2025-03-31Q1 FY2025 | 2025-05-09 | $0.00 | $462.3M | +100.0% | +33.3% | $-0.07 | +100.0% |
| 2024-12-31Q4 FY2024 | 2025-03-03 | $-0.03 | $337.0M | +78.6% | +7.9% | $-0.07 | +57.1% |
| 2024-09-30Q3 FY2024 | 2024-11-08 | $-0.02 | $331.0M | +77.8% | +8.2% | $-0.01 | -50.4% |
| 2024-06-30Q2 FY2024 | 2024-08-08 | $0.01 | $356.3M | +116.7% | +11.3% | $-0.05 | +120.0% |
| 2024-03-31Q1 FY2024 | 2024-05-07 | $-0.05 | $346.9M | +66.7% | +7.7% | $-0.07 | +28.6% |
| 2023-12-31Q4 FY2023 | 2024-03-14 | $-0.14 | $312.4M | +17.6% | +121.1% | $-0.18 | +22.2% |
| 2023-09-30Q3 FY2023 | 2023-11-06 | $-0.09 | $306.0M | +43.8% | -64.3% | $-0.10 | +10.0% |
| 2023-06-30Q2 FY2023 | 2023-08-08 | $-0.06 | $320.1M | +72.7% | -62.2% | $-0.13 | +53.8% |
| 2023-03-31Q1 FY2023 | 2023-05-09 | $-0.15 | $322.0M | +6.3% | -63.2% | $-0.19 | +21.1% |
| 2022-12-31Q4 FY2022 | 2023-03-01 | $-0.17 | $-1.48B | +60.5% | -442.9% | $-0.34 | +50.0% |
| 2022-09-30Q3 FY2022 | 2022-11-07 | $-0.16 | $856.8M | -100.0% | +100.6% | $-0.31 | +48.4% |
| 2022-06-30Q2 FY2022 | 2022-08-08 | $-0.22 | $846.7M | +71.8% | +105.3% | $-0.23 | +4.3% |
| 2022-03-31Q1 FY2022 | 2022-05-09 | $-0.16 | $874.4M | -23.1% | +336.5% | $-0.24 | +33.3% |
| 2021-12-31Q4 FY2021 | 2022-02-28 | $-0.43 | $432.0M | +72.6% | +159.9% | $-0.26 | -65.4% |
| 2021-09-30Q3 FY2021 | 2021-11-09 | $-0.08 | $427.2M | -500.0% | +152.7% | $-0.31 | +74.2% |
| 2021-06-30Q2 FY2021 | 2021-08-11 | $-0.78 | $412.5M | -7900.0% | +139.7% | $-0.17 | -358.8% |
| 2021-03-31Q1 FY2021 | 2021-05-17 | $-0.13 | $200.3M | — | +21.0% | $-0.12 | -8.3% |
| 2020-12-31Q4 FY2020 | 2021-03-31 | $-1.57 | $166.2M | — | — | — | — |
| 2020-09-30Q3 FY2020 | 2020-11-16 | $0.02 | $169.1M | +101.7% | +42.8% | — | — |
| 2020-06-30Q2 FY2020 | 2020-08-13 | $0.01 | $172.1M | +100.4% | +45.9% | — | — |
| 2020-03-31Q1 FY2020 | 2020-06-04 | $0.00 | $165.5M | +100.0% | +40.4% | — | — |
| 2019-12-31Q4 FY2019 | 2021-03-31 | $0.00 | $0 | — | — | — | — |
| 2019-09-30Q3 FY2019 | 2019-09-30 | $-1.21 | $118.4M | — | — | — | — |
| 2019-06-30Q2 FY2019 | 2019-06-30 | $-2.76 | $117.9M | — | — | — | — |
| 2019-03-31Q1 FY2019 | 2019-03-31 | $-2.76 | $117.9M | — | — | — | — |